The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: A U.S. SEER database analysis

PURPOSE: Women under 40 years old are at increased risk for developing human epidermal growth factor receptor 2 (HER2) positive or triple negative subtype and more advanced breast cancer, yet young age itself has also historically been an independent prognostic factor. METHODS: Using the Surveillanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee Jeong, Kim, Seonok, Freedman, Rachel A., Partridge, Ann H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693310/
https://www.ncbi.nlm.nih.gov/pubmed/34923225
http://dx.doi.org/10.1016/j.breast.2021.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693310/
https://www.ncbi.nlm.nih.gov/pubmed/34923225
http://dx.doi.org/10.1016/j.breast.2021.12.006

Ejemplares similares